Scinovex
articleTop 10% cited

Isolation of Dolastatin 10 from the Marine Cyanobacterium <i>Symploca</i> Species VP642 and Total Stereochemistry and Biological Evaluation of Its Analogue Symplostatin 1

Journal of Natural Products · 2001 · Vol. 64(7) · pp. 907–910
Hendrik LueschRichard E. MooreValerie J. PaulSusan L. MooberryThomas H. Corbett

Abstract

The potent antitumor agent dolastatin 10 (1) was originally isolated from the sea hare Dolabella auricularia, and we now report its isolation from the marine cyanobacterium Symploca sp. VP642 from Palau. The chemically related analogue symplostatin 1 (2) has been reisolated from Guamanian and Hawaiian varieties of S. hydnoides and its total stereochemistry completed by determining the N,N-dimethylisoleucine unit to be L. Symplostatin 1 (2), like dolastatin 10 (1), is a potent microtubule inhibitor. The antitumor activity of 2 was assessed in vivo against several murine tumors. Symplostatin 1 (2) was effective against a drug-insensitive mammary tumor and a drug-insensitive colon tumor; however, it was only slightly effective against two MDR tumors.

Microbial Natural Products and BiosynthesisCancer Treatment and PharmacologyMarine Sponges and Natural ProductsDepsipeptideBiologyIsolation (microbiology)In vivoStereochemistryPharmacognosyBiological activityIn vitroChemistryBiochemistry

MeSH terms

CyanobacteriaAnimalsAntineoplastic AgentsAplysiaChromatography, High Pressure LiquidCytotoxinsFemaleFibroblastsFluorescent Antibody TechniqueGuamHawaiiHumansNeoplasmsMagnetic Resonance SpectroscopyOligopeptides
Citations
373
FWCI
3.21
field-weighted impact
References
12
Percentile
91%
vs. same field & year
Citations per year
References
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
JNCI Journal of the National Cancer Institute · 1990 · 9,711 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.